Emerging frontiers in drug release control by core-shell nanofibers: a review

被引:39
作者
Monfared, Mohammad [1 ,2 ]
Taghizadeh, Saeed [3 ]
Zare-Hoseinabadi, Alireza [1 ]
Mousavi, Seyyed Mojtaba [1 ]
Hashemi, Seyyed Alireza [1 ]
Ranjbar, Saba [4 ]
Amani, Ali Mohammad [1 ]
机构
[1] Shiraz Univ Med Sci, Dept Med Nanotechnol, Sch Adv Med Sci & Technol, Shiraz, Iran
[2] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran
[3] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Med Biotechnol, Shiraz, Iran
[4] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Irvine, CA USA
关键词
Core-shell; electrospinning; nanofibers; controlled drug release; BONE MORPHOGENETIC PROTEIN-2; ATOMIC LAYER DEPOSITION; POLYMER NANOFIBERS; ELECTROSPUN NANOFIBERS; COMPOSITE NANOFIBERS; ULTRAFINE FIBERS; DELIVERY SYSTEMS; SUSTAINED-RELEASE; CORE/SHELL FIBERS; DIAMETER FIBERS;
D O I
10.1080/03602532.2019.1642912
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In recent years, core-shell (CS) nanofiber has widely been used as a carrier for controlled drug release. This outstanding attention toward CS nanofiber is mainly due to its tremendous significance in controllable drug release in specific locations. The major advantage of CS nanofibers is forming a highly porous mesh, boosting its performance for many applications, due to its large surface-to-volume ratio. This inherently high ratio has prompted electrospun fibers to be considered one of the best drug-delivery-systems available, with the capacity to enhance properties such as cell attachment, drug loading, and mass transfer. Using electrospun fibers as CS nanofibers to incorporate different cargos such as antibiotics, anticancer agents, proteins, DNA, RNA, living cells, and diverse growth factors would considerably satisfy the need for a universal carrier in the field of nanotechnology. In addition to their high surface area, other benefit included in these nanofibers is the ability to trap drugs, easily controlled morphology, and their biomimetic characteristics. In this review, by taking the best advantages of the preparation and uses of CS nanofibers, a novel work in the domain of the controlled drug delivery by nanofiber-based scaffolds is presented.
引用
收藏
页码:589 / 611
页数:23
相关论文
共 135 条
[1]   Release Profiles of Tricalcium Phosphate Nanoparticles from Poly(L-lactic acid) Electrospun Scaffolds with Single Component, Core-Sheath, or Porous Fiber Morphologies: Effects on hASC Viability and Osteogenic Differentiation [J].
Asli, Mahsa Mohiti ;
Pourdeyhimi, Behnam ;
Loboa, Elizabeth G. .
MACROMOLECULAR BIOSCIENCE, 2012, 12 (07) :893-900
[2]   Separation of micron to sub-micron particles from water: Electrospun nylon-6 nanofibrous membranes as pre-filters [J].
Aussawasathien, D. ;
Teerawattananon, C. ;
Vongachariya, A. .
JOURNAL OF MEMBRANE SCIENCE, 2008, 315 (1-2) :11-19
[3]  
Ball C, 2015, DRUG DELIVERY AND DEVELOPMENT OF ANTI-HIV MICROBICIDES, P459
[4]   Electrospun Solid Dispersions of Maraviroc for Rapid Intravaginal Preexposure Prophylaxis of HIV [J].
Ball, Cameron ;
Woodrow, Kim A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (08) :4855-4865
[5]   Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial [J].
Ballard, Clive ;
Jones, Emma ;
Gauge, Nathan ;
Aarsland, Dag ;
Nilsen, Odd Bjarte ;
Saxby, Brian K. ;
Lowery, David ;
Corbett, Anne ;
Wesnes, Keith ;
Katsaiti, Eirini ;
Arden, James ;
Amaoko, Derek ;
Prophet, Nicholas ;
Purushothaman, Balaji ;
Green, David .
PLOS ONE, 2012, 7 (06)
[6]   Nanofibers from Scalable Gas Jet Process [J].
Benavides, Rafael E. ;
Jana, Sadhan C. ;
Reneker, Darrell H. .
ACS MACRO LETTERS, 2012, 1 (08) :1032-1036
[7]   Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures [J].
Blakney, Anna K. ;
Krogstad, Emily A. ;
Jiang, Yonghou H. ;
Woodrow, Kim A. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 :2967-2978
[8]   Electrospun fibers for vaginal anti-HIV drug delivery [J].
Blakney, Anna K. ;
Ball, Cameron ;
Krogstad, Emily A. ;
Woodrow, Kim A. .
ANTIVIRAL RESEARCH, 2013, 100 :S9-S16
[9]  
Bognitzki M, 2001, ADV MATER, V13, P70, DOI 10.1002/1521-4095(200101)13:1<70::AID-ADMA70>3.0.CO
[10]  
2-H